Phase II clinical study with expanded study population and to further evaluate the clinical safety, immunogenicity and efficacy of the Hepatitis B Vaccine with PIKA Adjuvant.
Phase of Trial: Phase II
Latest Information Update: 02 Dec 2016
At a glance
- Drugs Hepatitis B vaccine (Primary)
- Indications Hepatitis B
- Focus Adverse reactions; Pharmacodynamics
- 02 Dec 2016 New trial record